Last reviewed · How we verify
Vaseline Topical Product
At a glance
| Generic name | Vaseline Topical Product |
|---|---|
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Diarrhea
- Hypertension
- Aspartate aminotransferase increased
- Local application site irritation
- Abdominal pain
- Anorexia
- Lymphocyte count decreased
- Alanine aminotransferase increased
- Nausea
- Anemia
- Fatigue
- Vomiting
Key clinical trials
- Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (PHASE2)
- Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer (PHASE1)
- Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction (NA)
- Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients (PHASE2)
- Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients (PHASE2)
- Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus (NA)
- Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
- Chlorhexidine and Garlic Extract as Potential Topical Virucidal Therapeutic Agents of Non-Genital Warts (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |